IDEAS home Printed from https://ideas.repec.org/d/chhamde.html

Publications

by members of

Universität Hamburg → Hamburg Center for Health Economics (HCHE)

University of Hamburg

These are publications listed in RePEc written by members of the above institution who are registered with the RePEc Author Service. Thus this compiles the works all those currently affiliated with this institution, not those affilated at the time of publication. List of registered members. Register yourself. Citation analysis. This page is updated in the first days of each month.
| Working papers | Journal articles |

Working papers

2019

  1. Bayindir, Esra E. & Gurdal, Mehmet Y. & Ozdogan, Ayca & Saglam, Ismail, 2019, "Cheap Talk Games with Two-Senders and Different Modes of Communication," MPRA Paper, University Library of Munich, Germany, number 97152, Nov.
  2. Bayindir, Esra Eren, 2019, "Hospital ownership type and service provision, a structural approach," hche Research Papers, University of Hamburg, Hamburg Center for Health Economics (hche), number 19.

2018

  1. Pohl, R. Vincent, 2018, "Time Trends Matter: The Case of Medical Cannabis Laws and Opioid Overdose Mortality," MPRA Paper, University Library of Munich, Germany, number 87237, Jun.
  2. Parro, Francisco & Pohl, R. Vincent, 2018, "Health Shocks, Human Capital, and Labor Market Outcomes," MPRA Paper, University Library of Munich, Germany, number 87238, Jun.
  3. Martin B. Hackmann & R. Vincent Pohl & Nicolas R. Ziebarth, 2018, "Patient Versus Provider Incentives in Long Term Care," NBER Working Papers, National Bureau of Economic Research, Inc, number 25178, Oct.
  4. Martin Benjamin Hackmann & R. Vincent Pohl, 2018, "Patient vs. Provider Incentives in Long-Term Care," CESifo Working Paper Series, CESifo, number 7373.
  5. Garin, Julio & Pohl, R. Vincent & Smith, Rhet A., 2018, "The Effect of Medical Cannabis Dispensaries on Opioid and Heroin Overdose Mortality," MPRA Paper, University Library of Munich, Germany, number 89613, Oct.
  6. Lehrer, Steven F. & Pohl, R. Vincent & Song, Kyungchul, 2018, "Multiple Testing and the Distributional Effects of Accountability Incentives in Education," MPRA Paper, University Library of Munich, Germany, number 89532, Sep.

2017

  1. Allen, Lindsay & Barkowski, Scott & Harris, Matthew & McLaughlin, Joanne Song & Pohl, R. Vincent & Skira, Meghan & Waldron, James, 2017, "Economics conference bingo," MPRA Paper, University Library of Munich, Germany, number 83074, Dec.
  2. Pohl, R. Vincent & Clark, Kathryn L. & Thomas, Ryan C., 2017, "Minimum Wages and Healthy Diet," MPRA Paper, University Library of Munich, Germany, number 87239, Jul.

2016

  1. Steven F. Lehrer & R. Vincent Pohl & Kyungchul Song, 2016, "Targeting Policies: Multiple Testing and Distributional Treatment Effects," NBER Working Papers, National Bureau of Economic Research, Inc, number 22950, Dec.

2014

  1. Vincent Pohl, 2014, "Medicaid and the Labor Supply of Single Mothers: Implications for Health Care Reform," Upjohn Working Papers, W.E. Upjohn Institute for Employment Research, number 15-222, May.

2012

  1. Stargardt, Tom & Schreyögg, Jonas & Kondofersky, Ivan, 2012, "Measuring the relationship between costs and outcomes: The example of Acute Myocardial Infarction in German hospitals," hche Research Papers, University of Hamburg, Hamburg Center for Health Economics (hche), number 2012/04.

2011

  1. Ismail Saglam & Esra Eren Bayindir & Mehmet Yigit Gurdal, 2011, "The dependence of health insurance availability on years left before Medicare," Koç University-TUSIAD Economic Research Forum Working Papers, Koc University-TUSIAD Economic Research Forum, number 1107, Mar.
  2. Roll, Kathrin & Stargardt, Tom & Schreyögg, Jonas, 2011, "Effect of type of insurance and income on waiting time for outpatient care," hche Research Papers, University of Hamburg, Hamburg Center for Health Economics (hche), number 2011/03.

2005

  1. Busse, Reinhard & Stargardt, Tom & Schreyögg, Jonas & Simon, Claudia & Martin, Maria, 2005, "Defining benefit catalogues and entitlements to health care in Germany: Decision makers, decision criteria and taxonomy of catalogues," Discussion Papers, Technische Universität Berlin, School of Economics and Management, number 2005/5.

2004

  1. Farhauer, Oliver & Borchardt, Katja & Stargardt, Tom, 2004, "Bürgerversicherung: Die Wirkung von Kopfprämien auf den Arbeitsmarkt," Discussion Papers, Technische Universität Berlin, School of Economics and Management, number 2004/8.

Journal articles

2026

  1. Bayindir, Esra Eren & Schreyögg, Jonas, 2026, "Trust and the impact of state interventions on healthcare utilization during the COVID-19 pandemic in Germany: An instrumental variables approach," Health Policy, Elsevier, volume 168, issue C, DOI: 10.1016/j.healthpol.2026.105598.

2024

  1. Bayindir, Esra Eren & Jamalabadi, Sara & Messerle, Robert & Schneider, Udo & Schreyögg, Jonas, 2024, "Hospital competition and health outcomes: Evidence from acute myocardial infarction admissions in Germany," Social Science & Medicine, Elsevier, volume 349, issue C, DOI: 10.1016/j.socscimed.2024.116910.

2023

  1. Pott, Clara & Stargardt, Tom & Frey, Simon, 2023, "Does prospective payment influence quality of care? A systematic review of the literature," Social Science & Medicine, Elsevier, volume 323, issue C, DOI: 10.1016/j.socscimed.2023.115812.

2021

  1. Esra Eren Bayindir & Jonas Schreyögg, 2021, "What drives different treatment choices? Investigation of hospital ownership, system membership and competition," Health Economics Review, Springer, volume 11, issue 1, pages 1-14, December, DOI: 10.1186/s13561-021-00305-3.
  2. Clara Pott & Tom Stargardt & Udo Schneider & Simon Frey, 2021, "Do discontinuities in marginal reimbursement affect inpatient psychiatric care in Germany?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), volume 22, issue 1, pages 101-114, February, DOI: 10.1007/s10198-020-01241-5.

2020

  1. Esra E. Bayindir & Mehmet Y. Gurdal & Ayca Ozdogan & Ismail Saglam, 2020, "Cheap Talk Games with Two-Senders and Different Modes of Communication," Games, MDPI, volume 11, issue 2, pages 1-22, April.
  2. Mathias Baumann & Tom Stargardt & Simon Frey, 2020, "Cost–Utility of Internet-Based Cognitive Behavioral Therapy in Unipolar Depression: A Markov Model Simulation," Applied Health Economics and Health Policy, Springer, volume 18, issue 4, pages 567-578, August, DOI: 10.1007/s40258-019-00551-x.

2019

  1. Bayindir, Esra Eren & Gurdal, Mehmet Yigit & Saglam, Ismail, 2019, "A Game Theoretic Approach to Peer Review of Grant Proposals," Journal of Informetrics, Elsevier, volume 13, issue 4, DOI: 10.1016/j.joi.2019.100981.
  2. Simon Frey & Tom Stargardt & Udo Schneider & Jonas Schreyögg, 2019, "The Economic Burden of Cystic Fibrosis in Germany from a Payer Perspective," PharmacoEconomics, Springer, volume 37, issue 8, pages 1029-1039, August, DOI: 10.1007/s40273-019-00797-2.

2018

  1. R. Vincent Pohl, 2018, "Medicaid And The Labor Supply Of Single Mothers: Implications For Health Care Reform," International Economic Review, Department of Economics, University of Pennsylvania and Osaka University Institute of Social and Economic Research Association, volume 59, issue 3, pages 1283-1313, August, DOI: 10.1111/iere.12304.

2017

  1. Jeon, Sung-Hee & Pohl, R. Vincent, 2017, "Health and work in the family: Evidence from spouses’ cancer diagnoses," Journal of Health Economics, Elsevier, volume 52, issue C, pages 1-18, DOI: 10.1016/j.jhealeco.2016.12.008.
  2. Carl Rudolf Blankart & Tom Stargardt, 2017, "Preferred supplier contracts in post-patent prescription drug markets," Health Care Management Science, Springer, volume 20, issue 3, pages 419-432, September, DOI: 10.1007/s10729-016-9362-6.
  3. Dmitrij Achelrod & Jonas Schreyögg & Tom Stargardt, 2017, "Health-economic evaluation of home telemonitoring for COPD in Germany: evidence from a large population-based cohort," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), volume 18, issue 7, pages 869-882, September, DOI: 10.1007/s10198-016-0834-x.

2016

  1. Simon Frey & Carl R. Blankart & Tom Stargardt, 2016, "Economic Burden and Quality-of-Life Effects of Chronic Lymphocytic Leukemia: A Systematic Review of the Literature," PharmacoEconomics, Springer, volume 34, issue 5, pages 479-498, May, DOI: 10.1007/s40273-015-0367-7.
  2. Katharina Elisabeth Fischer & Tom Stargardt, 2016, "The diffusion of generics after patent expiry in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), volume 17, issue 8, pages 1027-1040, November, DOI: 10.1007/s10198-015-0744-3.
  3. Achelrod, Dmitrij & Welte, Tobias & Schreyögg, Jonas & Stargardt, Tom, 2016, "Costs and outcomes of the German disease management programme (DMP) for chronic obstructive pulmonary disease (COPD)—A large population-based cohort study," Health Policy, Elsevier, volume 120, issue 9, pages 1029-1039, DOI: 10.1016/j.healthpol.2016.08.002.
  4. Guhl, Dennis & Stargardt, Tom & Schneider, Udo & Fischer, Katharina E., 2016, "Dispensing behaviour of pharmacies in prescription drug markets," Health Policy, Elsevier, volume 120, issue 2, pages 190-197, DOI: 10.1016/j.healthpol.2016.01.010.
  5. Fischer, Katharina Elisabeth & Heisser, Thomas & Stargardt, Tom, 2016, "Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and Australia," Health Policy, Elsevier, volume 120, issue 10, pages 1115-1122, DOI: 10.1016/j.healthpol.2016.08.001.
  6. Florian Hofer & Dmitrij Achelrod & Tom Stargardt, 2016, "Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany," Applied Health Economics and Health Policy, Springer, volume 14, issue 6, pages 691-701, December, DOI: 10.1007/s40258-016-0267-9.

2015

  1. Esra Eren Bayindir & Mehmet Yigit Gurdal & Ismail Saglam, 2015, "Does time to Medicare eligibility affect the likelihood of being uninsured?," Economics Bulletin, AccessEcon, volume 35, issue 3, pages 1589-1597.

2014

  1. Esra Eren BAYINDIR & Armağan Can EVCİ, 2014, "Ülkelerarası ortak akademik çalışmalar kaliteli yayın miktarını arttırıyor mu?," Iktisat Isletme ve Finans, Bilgesel Yayincilik, volume 29, issue 335, pages 09-22.
  2. Simon Frey & Roland Linder & Georg Juckel & Tom Stargardt, 2014, "Cost-effectiveness of long-acting injectable risperidone versus flupentixol decanoate in the treatment of schizophrenia: a Markov model parameterized using administrative data," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), volume 15, issue 2, pages 133-142, March, DOI: 10.1007/s10198-013-0460-9.
  3. Dmitrij Achelrod & Tom Stargardt, 2014, "Cost-Utility Analysis Comparing Heavy-Weight and Light-Weight Mesh in Laparoscopic Surgery for Unilateral Inguinal Hernias," Applied Health Economics and Health Policy, Springer, volume 12, issue 2, pages 151-163, April, DOI: 10.1007/s40258-014-0082-0.
  4. Tom Stargardt & Jonas Schreyögg & Ivan Kondofersky, 2014, "Measuring The Relationship Between Costs And Outcomes: The Example Of Acute Myocardial Infarction In German Hospitals," Health Economics, John Wiley & Sons, Ltd., volume 23, issue 6, pages 653-669, June, DOI: 10.1002/hec.2941.

2013

  1. Vandoros, Sotiris & Stargardt, Tom, 2013, "Reforms in the Greek pharmaceutical market during the financial crisis," Health Policy, Elsevier, volume 109, issue 1, pages 1-6, DOI: 10.1016/j.healthpol.2012.08.016.
  2. Laura Haas & Tom Stargardt & Jonas Schreyoegg & Rico Schlösser & Burghard Klapp & Gerhard Danzer, 2013, "The Trade-off Between Costs and Quality of Care in the Treatment of Psychosomatic Patients with Somatoform Pain Disorder," Applied Health Economics and Health Policy, Springer, volume 11, issue 4, pages 359-368, August, DOI: 10.1007/s40258-013-0042-0.

2012

  1. Bayindir, Esra Eren, 2012, "Hospital ownership type and treatment choices," Journal of Health Economics, Elsevier, volume 31, issue 2, pages 359-370, DOI: 10.1016/j.jhealeco.2012.01.003.
  2. Hendrik Jürges & Vincent Pohl, 2012, "Medical guidelines, physician density, and quality of care: evidence from German SHARE data," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), volume 13, issue 5, pages 635-649, October, DOI: 10.1007/s10198-011-0372-5.
  3. Stargardt, Tom & Schreyögg, Jonas, 2012, "A framework to evaluate the effects of small area variations in healthcare infrastructure on diagnostics and patient outcomes of rare diseases based on administrative data," Health Policy, Elsevier, volume 105, issue 2, pages 110-118, DOI: 10.1016/j.healthpol.2012.01.011.
  4. Kathrin Roll & Tom Stargardt & Jonas Schreyögg, 2012, "Effect of Type of Insurance and Income on Waiting Time for Outpatient Care," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, volume 37, issue 4, pages 609-632, October.
  5. Laura Haas & Tom Stargardt & Jonas Schreyoegg, 2012, "Cost-effectiveness of open versus laparoscopic appendectomy: a multilevel approach with propensity score matching," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), volume 13, issue 5, pages 549-560, October, DOI: 10.1007/s10198-011-0355-6.
  6. Michael Bäumler & Tom Stargardt & Jonas Schreyögg & Reinhard Busse, 2012, "Cost Effectiveness of Drug-Eluting Stents in Acute Myocardial Infarction Patients in Germany," Applied Health Economics and Health Policy, Springer, volume 10, issue 4, pages 235-248, July, DOI: 10.2165/11597340-000000000-00000.

2011

  1. Tom Stargardt, 2011, "Modelling pharmaceutical price changes in Germany: a function of competition and regulation," Applied Economics, Taylor & Francis Journals, volume 43, issue 29, pages 4515-4526, DOI: 10.1080/00036846.2010.491470.
  2. Michael Drummond & Bengt Jönsson & Frans Rutten & Tom Stargardt, 2011, "Reimbursement of pharmaceuticals: reference pricing versus health technology assessment," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), volume 12, issue 3, pages 263-271, June, DOI: 10.1007/s10198-010-0274-y.
  3. Jonas Schreyögg & Tom Stargardt & Oliver Tiemann, 2011, "Costs and quality of hospitals in different health care systems: a multi‐level approach with propensity score matching," Health Economics, John Wiley & Sons, Ltd., volume 20, issue 1, pages 85-100, January, DOI: 10.1002/hec.1568.
  4. Carl Blankart & Tom Stargardt & Jonas Schreyögg, 2011, "Availability of and Access to Orphan Drugs," PharmacoEconomics, Springer, volume 29, issue 1, pages 63-82, January, DOI: 10.2165/11539190-000000000-00000.

2010

  1. Tom Stargardt, 2010, "The impact of reference pricing on switching behaviour and healthcare utilisation: the case of statins in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), volume 11, issue 3, pages 267-277, June, DOI: 10.1007/s10198-009-0172-3.

2007

  1. Stargardt, Tom & Schreyögg, Jonas & Busse, Reinhard, 2007, "Pricing behaviour of pharmacies after market deregulation for OTC drugs: The case of Germany," Health Policy, Elsevier, volume 84, issue 1, pages 30-38, November.

2006

  1. Jonas Schreyögg & Tom Stargardt & Oliver Tiemann & Reinhard Busse, 2006, "Methods to determine reimbursement rates for diagnosis related groups (DRG): A comparison of nine European countries," Health Care Management Science, Springer, volume 9, issue 3, pages 215-223, August, DOI: 10.1007/s10729-006-9040-1.

2005

  1. J. Schreyögg & T. Stargardt & M. Velasco-Garrido & R. Busse, 2005, "Defining the “Health Benefit Basket” in nine European countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), volume 6, issue 1, pages 2-10, November, DOI: 10.1007/s10198-005-0312-3.
  2. Reinhard Busse & Tom Stargardt & Jonas Schreyögg, 2005, "Determining the “Health Benefit Basket” of the Statutory Health Insurance scheme in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), volume 6, issue 1, pages 30-36, November, DOI: 10.1007/s10198-005-0316-z.

IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.